Synthesis and effects of active fragments of angiotensin II

Kidney International

Volumn 52, Issue 6, 1997, Pages 1458-1468

  Ardaillou, Raymond ^a   Chansel, Dominique ^a  

^a HÔPITAL TENON   (France)

Author keywords

Antiotensin II; Enzymes; Peptides; Receptors; Renin angiotensin system

Indexed keywords

ANGIOTENSIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME SYNTHESIS; GENE DELETION; HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0031435757     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.476     Document Type: Article

References (129)

1. BLAIR-WEST JR, COGHLAN JP, DENTON DA, FUNDER JW, SCOGGINS BA, WRIGHT RD: The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. J Clin Endocrinol Metab 32:575-578, 1971
2. BRAAM B, MITCHELL KD, FOX J, NAVAR LG: Proximal tubular secretion of angiotensin II in rats. Am J Physiol 264(Renal Fluid Electrol Physiol 33):F891-F898, 1993
3. SAIKALY MG, ARANT BS, SENEY F JR: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352-1357, 1990
4. WU Q, LI L, COOPER MD, PIERRES M, GORVEL JP: Aminopeptidase A activity of the murine B-lymphocyte differentiation antigen BP 1/6C3. Proc Natl Acad Sci USA 88:676-680, 1991
5. KUGLER P, WOLF G, SCHERBERICH J: Histochemical demonstration of peptidases in the human kidney. Histochemistry 83:337-341, 1985
6. KUGLER P: Histochemistry of angiotensinase A in the glomerulus and the juxtaglomerular apparatus. Kidney Int 22(Suppl 12):S44-S48, 1982
7. STEFANOVIC V, VLAHOVIC P, ARDAILLOU N, ARDAILLOU R: Receptor-mediated induction of aminopeptidase A of human glomerular epithelial cells by glucocorticoids. FEBS Lett 294:171-174, 1991
8. TROYANOVSKAYA M, SONG L, JAYARAMAN G, HEALY DP: Expression of aminopeptidase A, an angiotensinase, in glomerular mesangial cells. Hypertension 27:518-522, 1996
9. KUGLER P: Localization of aminopeptidase A (angiotensinase A) in the rat and mouse kidney. Histochemistry 72:269-278, 1981
10. ASSMANN KJM, VAN SON JPHF, DIJKMAN HBPW, KOENE RAP: A nephritogenic rat monoclonal antibody to mouse amino-peptidase A. Induction of massive albuminuria after a single intravenous injection. J Exp Med 175:623-635, 1992
11. MENTZEL S, ASSMANN KJM, DIJKMAN HBPM, DE JONG AS, VAN SON JPHJ, WETZELS JFM, KOENE RAP: Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: An angiotensin II-mediated effect? Nephrol Dial Transplant 11:2163-2169, 1996
12. STEFANOVIČ V, VLAHOVIČ P, ARDAILLOU N, RONCO P, ARDAILLOU R: Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int 41:1571-1580, 1992
13. LOOK AT, ASHMAN RA, SHAPIRO LH, PEIPER SC: Human myeloid plasma membrane glycoprotein CD13 (gp 150) is identical to aminopeptidase N. J Clin Invest 83:1299-1307, 1989
14. KENNY AJ, MAROUX S: Topology of microvillar membrane hydrolases of kidney and intestine. Physiol Rev 62:91-128, 1982
15. STEFANOVIČ V, VLAHOVIČ P, ARDAILLOU N, RONCO P, NIVEZ MP, ARDAILLOU R: Characterization and control of expression of cell surface aminopeptidase N activity in human mesangial glomerular cells. Cell Physiol Biochem 2:60-72, 1992
16. RONCO P, ANTOINE M, BAUDOUIN B, GENITEAU-LEGENDRE M, LELONGT B, CHATELET F, VERROUST P, VANDEWALLE A: Polarized membrane expression of brush border hydrolases in primary cultures of kidney proximal tubular cells depends on cell differentiation and is induced by dexamethasone. J Cell Physiol 27:518-522, 1990
17. WANG JM, BAUDHUIN P, COURTOY PJ, DE POTTER W: Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture. Endocrinology 136:5274-5282, 1995
18. NANUS DM, ENGELSTEIN D, GASTL GA, GLUCK L, VIDAL MJ, MORRISON M, FINSTAL CL, BANDER NH, ALBINO AP: Molecular cloning of the human kidney differentiation antigen gp 160: Human aminopeptidase A. Proc Natl Acad Sci USA 90:7069-7073, 1993
19. OLSEN J, COWELL GM, KONIGSHOFER E, DANIELSEN EM, MOLLER J, LAUSTEN L, HANSEN OC, WELINDER KG, ENGBERG J, HUNZIKER K, SPIESS M, SJÖSTRÖM H, NOREN O: Complete amino-acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett 238:307-314, 1988
20. HARDING JW, FELIX D: The effects of aminopeptidase inhibitors amastatin and bestatin on angiotensin-evokcd neuronal activity in rat brain. Brain Res 424:299-304, 1987
21. AHMAD S, WARD PE: Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther 252:643-650, 1990
22. CHAUVEL E, LLORENS-CORTES C, CORIC P, WILK S, ROQUES BP, FOURNIÉ-ZALUSKI MC: Differential inhibition of aminopeptidase A and aminopeptidase N by new β aminothiols. J Med Chem 37:2950-2957, 1994
23. FOURNIÉ-ZALUSKI MC, CORIC P, TURCAUD S, BRUETSCHY L, LUCAS E, WOBLE F, ROQUES BP: Potent and systemically active aminopeptidase N inhibitors designed from active site investigation. J Med Chem 35:1259-1266, 1992
24. LEE CM, SNYDER SH: Dipeptidylaminopeptidase III of rat brain. Selective affinity for enkephalin and angiotensin. J Biol Chem 257:12043-12050, 1982
25. ERDÖS EG: Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 16:363-370, 1990
26. CORVOL P, WILLIAMS TA, SOUBRIER F: Peptidyldipeptidase A: Angiotensin I-converting enzyme. Methods Enzymol 248:283-305, 1995
27. SOUBRIER F, ALHENC-GELAS F, HUBERT C, ALLEGRINI J, JOHN M, TREGAR G, CORVOL P: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390, 1988
28. SIBONY M, GASC JM, SOUBRIER F, ALHENC-GELAS F, CORVOL P: Gene expression and tissue localization of the two isoforms of angiotensin I-converting enzyme. Hypertension 21:827-835, 1993
29. LACHURIE ML, AZIZI M, GUYENE TT, ALHENC-GELAS F, MENARD J: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 91:2933-2942, 1995
30. UEDA S, ELLIOT HL, MORTON JJ, CONNELL JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin converting enzyme. Hypertension 25:1266-1269, 1995
31. CAMBIEN F, POIRIER O, LECART L, EVANS A, CAMBON JP, ARVELLER D, LUC G, BARD JM, BARAT L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
32. URATA H, HEALY B, STEWART RW, BUMBUS M, HUSAIN A: Angiotensin II-forming pathways in normal and failing hearts. Circ Res 66:883-890, 1990
33. SAUKER S, CHANDRASEKKARAN UM, WILK D, GLYNIAS MJ, KARNIK SS, HUSAIN A: Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation. J Biol Chem 31:2963-2968, 1997
34. ODYA CE, DALLY RD, GEORGIADIS KE: Specific high-affinity bradykinin binding by purified porcine kidney post-proline cleaving enzyme. Biochem Pharmacol 36:39-49, 1987
35. FRIEDMAN TC, ORLOWSKI M, WILK S: Prolylendopeptidase: Inhibition in vivo by N-benzyloxycarbonyl-prolyl-prolinol. J Neurochem 42:237-241, 1984
36. GAFFORD JT, SKIDGEL A, ERDOS EG, HERSH LB: Human kidney "enkephalinase", a neutral endopeptidase that cleaves active peptides. Biochemistry 22:3265-3271, 1983
37. YAMAMOTO K, CHAPPELL MC, BROSHNIHIAN B, FERRARIO C: In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 19:692-696, 1992
38. WELCHES WR, SANTOS RAS, CHAPPELI MC, BROSHNIHAN KB, GREENE LJ, FERRARIO CM: Evidence that prolylendopeptidase participates in the processing of brain angiotensin. J Hypertens 9:631-638, 1991
39. CHAPPELL MC, TALLANT EA, BROSNIHAN KB, FERRARIO CM: Conversion of angiotensin I to angiotensin (1-7) by thimet oligopeptidase (E.C. 3.4.24.15) in vascular smooth muscle cells. J Vasc Biol Med 5:129-137, 1995
40. TC cells. J Immunol 147:247-253, 1991
41. DEVYNCK MA, MEYER P: Angiotensin receptors. Biochem Pharmacol 27:1-5, 1978
42. 1) angiotensin II. Evidence and speculation for its role as an important agonist in the renin-angiotensin system. Circ Res 36:37:38-48, 1975
43. ROBERTSON MJ, CUNOOSAMY MP, CLARK KL: Effect of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta. Br J Pharmacol 106:166-172, 1992
44. 125I angiotensins in rat. J Neurochem 46:1292-1297, 1986
45. 125I] angiotensin II binding in pig aorta. Eur J Pharmacol 215:259-264, 1992
46. WOLF G, ASSMANN KJM, STAHL RAK: Overexpression of angiotensinase 1 in murine mesangial cells. (abstract) J Am Soc Nephrol 1:1643, 1996
47. VATTA MS, BIANCOTTI LG, LOCATELLI AS, PONCHADO ML, FERNANDEZ BE: Monophasic and biphasic effects of angiotensin II and III on norepinephrine uptake and release in rat adrenal medulla. Can J Physiol Pharmacol 70:821-825, 1992
48. FINK GD, BRUNER CA: Hypertension during chronic peripheral and central infusion of angiotensin III. Am J Physiol 249(Endocrinol Metab 12):E201-E208, 1985
49. PAPOUCHADO ML, VATTA MS, ESCALADA A, BIANCHIOTTI LG, FERNANDEZ BE: Angiotensin II modulates noradrenaline uptake and release in the rat hypothalamus. J Auton Pharmacol 15:1-8, 1995
50. WRIGHT JW, HARDING JW: Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Rev 17:227-262, 1992
51. ZINI S, FOURNÉ-ZALUSKI MC, CHAUVEL E, ROQUES BP, CORVOL P, LLORENS-CORTES C: Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors. Predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93:11968-11973, 1996
52. SIM MK, QIU XS: Formation of des-Asp angiotensin I in the hypothalamic extract of normo- and hypertensive rats. Blood Pressure 3:260-264, 1994
53. 2+ mobilization along the rat nephron. (abstract). J Am Soc Nephrol 7:1633, 1996
54. HARDING JW, JENSEN LL, HANESWORTH JM, ROBERTS KA, PAGE TA, WRIGHT JW: Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. Am J Physiol 262(Renal Fluid Electrol Physiol 31):F17-F23, 1992
55. WOLF G, THAISS F, MUELLER E, DISSER M, POOTH R, ZAHNER G, STAHL RAK: Glomerular mRNA expression of angiotensinase A after renal ablation. Exp Nephrol 3:240-248, 1995
56. THAISS F, WOLF G, ASSAD N, ZAHNER G, STAHL RAK: Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats. Diabetologia 39:275-280, 1996
57. SIM MK, YUAN HT: Effect of des-Asp angiotensin I on the contractile action of angiotensin II and angiotensin III. Eur J Pharmacol 28:175-178, 1995
58. WRIGHT JW, KREBS LT, STOBB JW, HARDING JW: The angiotensin IV system: Functional implications. Frontiers Neuroendocrinol 16:23-52, 1995
59. GRÖNE HJ, SIMON M, FUCHS E: Autoradiographic characterization of angiotensin receptor subtypes in fetal and adult human kidney. Am J Physiol 262(Renal Fluid Electrol Physiol 31):F326-F331, 1992
60. WOLF G, ZIYADEH FN, THEISS F, TOMASZEWSKI J, CARON RJ, WENZEL U, ZAHNER G, HELMCHEN U, STAHL RAK: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells; Role of the angiotensin type 2 receptor. J Clin Invest 100:1047-1058, 1977
61. BENNET JP JR, SNYDER SH: Angiotensin II binding to mammalian brain membranes. J Biol Chem 251:7423-7430, 1976
62. SWANSON GN, HANESWORTH JM, SARDINIA MF, COLEMAN JK, WRIGHT JW, HALL KL, MILLER-WING AV, STOBB JW, COOK VI, HARDING EC, HARDING JW: Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 40:409-419, 1992
63. FITZIMONS JT: The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J Physiol (London) 214:295-303, 1971
64. HALL L, HANESWORTH JM, BALL AE, FELGENHAUER GP, HOSICK HL, HARDING JW: Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pep 44:225-232, 1993
65. CZEKALSKI S, CHANSEL D, VANDERMEERSCH S, RONCO P, ARDAILLOU R: Evidence for angiotensin IV receptors in human collecting duct cells. Kidney Int 50:1125-1131, 1996
66. 4 receptors: Specificity and distribution. Kidney Int 46:1510-1512, 1994
67. WRIGHT JW, MILLER-WING AV, SHAFFER MJ, HIGGINSON C, WRIGHT DE, HANESWORTH JM, HARDING JW: Angiotensin II (3-8) [Ang IV] hippocampal binding: Potential role in the facilitation of memory. Brain Res Bull 32:497-502, 1993
68. KERINS DM, HAO Q, VAUGHAN DE: Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 96:2515-2520, 1995
69. BERNIER SG, SERVANT G, BOUDREAU M, FOURNIER A, GUILLEMETTE G: Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. Eur J Pharmacol 291:191-200, 1995
70. HANESWORTH JM, SARDINIA MF, KREBS LT, HALL KL, HARDING JW: Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther 266:1036-1042, 1993
71. DULIN N, MADHUN ZT, CHANG CH, BERTI-MATTERA L, DICKENS D, DOUGLAS JG: Angiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol 269(Renal Fluid Electrol Physiol 38):F644-F652, 1995
72. RIVA L, GALZIN AM: Pharmacological characterization of a specific binding site for angiotensin IV in cultured porcine aortic endothelial cells. Eur J Pharmacol 305:193-199, 1996
73. 4 receptors in bovine adrenal cortex. Peptides 15:1037-1044, 1994
74. 4 receptors structure- binding relationship: N-terminal modified angiotensin IV analogues. Peptides 15:1399-1406, 1994
75. 4 receptor in the brain. J Neurochem 68:2530-2537, 1997
76. PIOT JM, ZHAO Q, GUILLOCHON D, RICART G, THOMAS D: Isolation and characterization of two opiod peptides from a bovine hemoglobin peptic hydrolysate. Biochem Biophys Res Commun 189:101-110, 1992
77. ZHAO O, SANNIER F, GARREAU I, GUILLOCHON D, PIOT JM: Inhibition and inhibition kinetics of angiotensin converting enzyme activity by haemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem Biophys Res Commun 204:216-223, 1994
78. CAIN MD, CATT KJ, COGHLAN JP: Immunoreactive fragments of angiotensin II in blood. Nature 223:617-618, 1969
79. HABERL RL, DECKER PY, EINHAUPL KM: Angiotensin degradation products mediate endothelium-dcpendent dilution of rabbit brain arterioles. Circ Res 68:1621-1627, 1991
80. CHENG DY, DE WITT J, DENT EL, NOSSAMAN BD, KADOWITZ PJ: Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat. Eur J Pharmacol 261:223-227, 1994
81. NOSSAMAN BD, FENG CJ, KAYE AD, KADOWITZ PJ: Analysis of responses to Ang IV: Effects of PD-123319 and DUP-753 in the pulmonary circulation of the rat. Am J Physiol 268(Lung Cell Mol Physiol 12):L302-L308, 1995
82. GARRISON EA, KADOWITZ PJ: Analysis of responses to angiotensin I-(3-10) in the hindlimb vascular bed of the cat. Am J Physiol 270(Heart Circ Physiol 39):H1172-H1177, 1996
83. WRIGHT JW, AMIN HZ, MURRAY CE, ROBERTS KA, HARDING JW, MIZUTANI S, WARD PE: Use of aminopeptidase M as a hypotensive agent in spontaneously hypertensive rats. Brain Res Bull 27:545-551, 1991
84. WANG L, EBERHARD M, ERNE P: Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci 88:557-562, 1995
85. BAKER KM, ACETO JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259(Heart Circ Physiol 28):H610-H618, 1990
86. ROBERTS KA, KREBS LT, KRAMAR EO, SHAFFER MJ, HARDING JW, WRIGHT JW: Autoradiographic identification of brain angiotensin IV binding sites and differential C-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res 682:13-21, 1995
87. KOHARA K, BROSNIHAN KB, CHAPPELL MC, KHOSLA MC, FERRARIO CM: Angiotensin (1-7): A member of circulating angiotensin peptides. Hypertension 17:131-138, 1991
88. ADMIRAAL PJJ, DERKX FHM, DANSER AHJ, PIETERMAN H, SCHALEKAMP MADH: Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis. Hypertension 16:555-563, 1990
89. STEPHENSON SL, KENNY AJ: Metabolism of neuropeptides. Biochem J 241:237-247, 1987
90. MORIGUCHI A, BROSNIHAN KB, KUMAGAI H, GANTEN D, FERRARIO CM: Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol 266(Regul Integr Comp Physiol 35):R1273-R1279, 1994
91. LUQUE M, MARTIN P, MARTELL N, FERNANDEZ C, BROSNIHAN KB, FERRARIO CM: Effects of captopril related to increased levels of prostacyclin and angiotensin (1-7) in essential hypertension. J Hypertens 14:799-805, 1996
92. FERRARIO CM, BROSNIHAN KB, DIZ DI, JAISWAL N, KHOSLA MC, MILSTED A, TALLANT EA: Angiotensin (1 [hyphen7): A new hormone of the angiotensin system. Hypertension 18(Suppl III):III-126-III-133, 1991
93. DIZ DI, FERRARIO CM: Angiotensin receptor heterogeneity in the dorsal medulla oblongata as defined by angiotensin (1-7), in Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors. edited by RAIZADA MK, PHILLIPS MI, SUMNERS C, New York, Plenum Press, 1996, pp 225-235
94. TALLANT EA, LU X, WEISS RB, CHAPPELL MC, FERRARIO CM: Bovine aortic endothelial cells contain an angiotensin (1-7) receptor. Hypertension 29:388-393, 1997
95. SANTOS RAS, CAMPAGNOLE-SANTOS MJ, BARACHO NCV, FONTES MAP, SILVA LCS, NEVES LAA, OLIVEIRA DR, CALIGIORNE SM, RODRIGUES ARV, GROPEN C JR, CARVALHO WS, SILVA ACSE, KHOSLA MC: Characterization of a new angiotensin antagonist selective for angiotensin (1-7): Evidence that the actions of angiotensin (1-7) are mediated by specific angiotensin receptors. Brain Res Bull 35:293-298, 1994
96. ERNSBERGER P, ZHOU J, DAMON TH, DOUGLAS JG: Angiotensin II receptor subtypes in cultured rat mesangial cells. Am J Physiol 263(Renal Fluid Electrol Physiol 32 ):F411-F416, 1992
97. 3H] norepinephrine from rat atria. Hypertension 24:457-460, 1994
98. GARCIA NH, GARVIN JL: Angiotensin (1-7) has a biphasic effect on fluid absorption in the proximal straight tubule. J Am Soc Nephrol 5:1133-1138, 1994
99. HANDA RJ, FERRARIO CM, STRANDHOY JW: Renal actions of angiotensin (1-7): In-vivo and in-vitro studies. Am J Physiol 270(Renal Fluid Electrolte Physiol 39):F14-F147, 1996
100. MAHON JM, CARR RD, NICOL AK, HENDERSON IW: Angiotensin (1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertension 12:1377-1381, 1994
101. BROSNIHAN KB, LI P, FERRARIO CM: Angiotensin (1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27:523-528, 1996
102. PORSTI I, BARA AT, BUSSE R, HECKER M: Release of nitric oxide by angiotensin (1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 111:652-654, 1994
103. MENG W, BUSIJA DW: Comparative effects of angiotensin (1-7) and angiotensin II on piglet pial arterioles. Stroke 24:2041-2045, 1993
104. OSEI SY, AHIMA RS, MINKES RK, WEAVER JP, KHOSLA MC, KADOWITZ PJ: Differential responses to angiotensin (1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 234:35-42, 1993
105. BENTER IF, FERRARIO CM, MORRIS M, DIZ DZ: Antihypertensive actions of angiotensin (1-7) in spontaneously hypertensive rats. Am J Physiol 269(Heart Circ Physiol 38):H313-H319, 1995
106. NAKAMOTO H, FERRARIO CM, FULLER SB, ROBACZWSKI DL, WINICOV E, DEAN RH: Angiotensin (1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 25:796-802, 1995
107. MORIGUCHI A, TALLANT EA, MATSUMURA K, REILLY TM, WALTON H, GANTEN D, FERRARIO CM: Opposing actions of angiotensin (1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension 25:1260-1265, 1995
108. BENTER IF, DIZ DI, FERRARIO CM: Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin (1-7). Hypertension 26:1138-1144, 1995
109. FREEMAN EJ, CHISOLM GM, FERRARIO CM, TALLANT EA: Angiotensin (1-7) inhibits vascular smooth muscle cell growth. Hypertension 28:104-108, 1996
110. SANTOS RAS, SIMOES E SILVA AC, MAGALDI AJ, KHOSLA MC, CESAR KR, PASSAGLIO KT, BARACHO NCV: Evidence for a physiological role of angiotensin (1-7) in the control of hydroelectrolyte balance. Hypertension 27:875-884, 1996
111. 2 release. Hypertension 25:1238-1244, 1995
112. DELLI PIZZI A, HILCHEY SD, BELL-QUILLEY CP: Natriuretic actions of angiotensin (1-7). Br J Pharmacol 111:1-4, 1994
113. 2 activity and sodium transport by angiotensin (1-7). Kidney Int 44:932-936, 1993
114. BOTELHO LM, BLOCK CH, KHOSLA MC, SANTOS RAS: Plasma angiotensin (1-7) level is increased by water deprivation, salt load and hemorrhage. Peptides 15:723-729, 1994
115. SCHIAVONE MT, SANTOS RAS, BROSNIHAN KB, KHOSLA MC, FERRARIO CM: Release of vasopressin from the rat hypothalamoneurohypophysial system by angiotensin (1-7) heptapeptide. Proc Natl Acad Sci USA 85:4095-4098, 1988
116. FELIX D, KHOSLA MC, IMBODEM H, MONTANI B, FERRARIO CM: Neurophysiological responses to angiotensin (1-7). Hypertension 17: 1111-1114, 1991
117. BLOCK CH, SANTOS RAS, BROSNIHAN KB, FERRARIO CM: Immunocytochemical localization of angiotensin (1-7) in the rat forebrain. Peptides 9:1395-1401, 1988
118. JAISWAL N, DIZ DI, CHAPPEL MC, KHOSLA M, FERRARIO CM: Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors. Hypertension 19(Suppl II):49-55, 1992
119. JAISWAL N, JAISWAL RF, TALLANT EA, DIZ DI, FERRARIO CM: Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension 21:400-905, 1993
120. JAISWAL N, TALLANT EA, DIZ DI, KHOSLA MC, FERRARIO CM: Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension 17:1115-1120, 1991
121. JAISWAL N, DIZ DI, TALLANT EA, KHOSLA MC, FERRARIO CM: Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol 260(Regul Integr Comp Physiol 29):R1000-R1006, 1991
122. TRACHTE GJ, MEIXNER K, FERRARIO CM, KHOSLA MC: Prostaglandin production in response to angiotensin (1-7) in rabbit isolated vasa deferentia. Prostaglandins 39:385-394, 1990
123. LI P, CHAPPELL MC, FERRARIO CM, BROSNIHAN KB: Angiotensin (1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29:394-400, 1997
124. DE SILVA PE, HUSAIN A, SMEBY RR, KHAIRALLAH PA: Measurement of immunoreactive angiotensin peptides in rat tissues: Some pitfalls in angiotensin II analysis. Anal Biochem 174:80-87, 1988
125. BRASZKO JJ, KULAKOWSKA A, WISNIEWSKI K: Angiotensin II and its 3-7 fragment improve recognition but not spatial memory in rats. Brain Res Bull 37:627-631, 1995
126. BRASZKO J, KULAKOWSKA A, KARWOWSKA W, WISNIEWSKI K: Effect of losartan on the memory enhancing activity of angiotensin II and angiotensin II (3-7). Pol J Pharmacol 4:263-264, 1994
127. MATSUFUJI H, MATSUI T, OHSHIGE S, KAWASAKI T, OSAJIMA K, OSAJIMA Y: Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotech Biochem 59:1398-1401, 1995
128. CAMPBELL D, LAWRENCE AC, TOWRIE A, KLADIS A, VALENTIJIN AJ: Differential regulation of angiotensin peptide levels in plasma and kidney or the rat. Hypertension 18:763-773, 1991
129. SNYDER RA, WINTROUB BU: Inhibition of angiotensin-converting enzyme by des-leu10-angiotensin I: A potential mechanism of andogenous angiotensins converting enzyme inhibition. Biochem Biophys Acta 871:1-5, 1986